[Anti-osteoporosis drugs : their characteristics and evidence for anti-fracture efficacy].

Remarkable progress in development of anti-fracture drugs has been achieved. Now we have anti-resorptive drugs, bisphosphonates and selective estrogen receptor modulators (SERMs) , bone anabolic one, teriparatide, and active vitamin D(3) analogues, alfacalcidol and eldecalcitol. Accumulating evidence shows their anti-fracture efficacy and safety profiles. We should learn fundamental evidence of those medicines as prescribing them to patients with osteoporosis.